G Model
CCLET 3840 1–5
H.-T. Jiang et al. / Chinese Chemical Letters xxx (2016) xxx–xxx
5
268
269
[2] T. Mukai, N. Suganuma, K. Soejima, et al., Synthesis of
b
-tetrapeptide analog as -amino acids, their a-hydroxy derivatives, and the N-terminal components
b
226
227
a mother compound for the development of matrix metalloproteinase-2-
imaging agents, Chem. Pharm. Bull. 56 (2008) 260–265.
[3] (a) A.E. Weber, Dipeptidyl peptidase IV inhibitors for the treatment of diabetes,
J. Med. Chem. 47 (2004) 4135–4141;
of bestatin and microginin, Helv. Chim. Acta 79 (1996) 1203–1216.
[10] C. Miniejew, F. Outurquin, X. Pannecoucke, Diastereoselective synthesis of
aziridine esters via amino selanyl esters, Tetrahedron 62 (2006) 2657–2670.
[11] C. Palomo, M. Oiarbide, R. Halder, et al., Catalytic enantioselective conjugate
addition of carbamates, J. Am. Chem. Soc. 126 (2004) 9188–9189.
270
271
228
229
230
231
232
233
234
235
236
237
238
239
(b) S.H. Havale, M. Pal, Medicinal chemistry approaches to the inhibition of
dipeptidyl peptidase-4 for the treatment of type 2 diabetes, Bioorg. Med.
Chem. 17 (2009) 1783–1802;
[12] R.F. Jackson, I. Rilatt, P.J. Murray, The rate of elimination of a
b-amino zinc
272
273
reagent is reduced by using a better leaving group, Chem. Commun. (2003)
1242–1243.
[13] (a) S.G. Nelson, K.L. Spencer, W.S. Cheung, et al., Divergent reaction pathways
(c) N.A. Thornberry, A.E. Weber, Discovery of JANUVIATM (Sitagliptin), a
selective dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes,
Curr. Top. Med. Chem. 7 (2007) 557–568;
274
275
276
277
278
in amine additions to
b-lactone electrophiles. An application to b-peptide
(d) C.H.S. Mclntosh, Dipeptidyl peptidase IV inhibitors and diabetes therapy,
Front. Biosci. 13 (2008) 1753–1773;
(e) A.A. Desai, Sitagliptin manufacture: a compelling tale of green chemistry,
process intensification, and industrial asymmetric catalysis, Angew. Chem. Int.
Ed. 50 (2011) 1974–1976.
synthesis, Tetrahedron 58 (2002) 7081–7091;
(b) K.B. Hansen, J. Balsells, S. Dreher, et al., First generation process for the
preparation of the DPP-IV inhibitor sitagliptin, Org. Process Res. Dev. 9 (2005)
634–639.
[14] S.B. Zhou, J. Wang, X. Chen, et al., Chemical kinetic resolution of unprotected
279
280
[4] (a) R.P.S. Cheng, H. Gellman, W.F. DeGrado,
b-Peptides: from structure to
b-substituted b-amino acids using recyclable chiral ligands, Angew. Chem. Int.
Ed. 53 (2014) 7883–7886.
[15] (a) Y.K. Chen, M. Yoshida, D.W.C. Macmillanm, Enantioselective
organocatalytic amine conjugate addition, J. Am. Chem. Soc. 128 (2006)
9328–9329;
240
241
242
function, Chem. Rev. 101 (2001) 3219–3232;
(b) D. Seebach, J. Gardiner,
b-Peptidic peptidomimetics, Acc. Chem. Res. 41
281
282
283
284
285
286
287
288
289
290
291
(2008) 1366–1375.
[5] (a) K.B. Hansen, J. Balsells, S. Dreher, et al., First generation process for the
preparation of the DPP-IV inhibitor sitagliptin, Org. Process Res. Dev. 9 (2005)
634–639;
243
244
245
246
247
248
(b) I. Ibrahem, R. Rios, J. Vesely, et al., Organocatalytic asymmetric 5-
hydroxyisoxazolidine synthesis: a highly enantioselective route to b-amino
acids, Chem. Commun. (2007) 849–851;
(b) K.B. Hansen, Y. Hsiao, F. Xu, et al., Highly efficient asymmetric synthesis of
sitagliptin, J. Am. Chem. Soc. 131 (2009) 8798–8804;
(c) D. Steinhuebel, Y. Sun, K. Matsumura, et al., Direct asymmetric reductive
amination, J. Am. Chem. Soc. 131 (2009) 11316–11317.
(c) O.V. Maltsev, A.S. Kucherenko, A.L. Chimishkyan, et al.,
derived chiral ionic liquids: recoverable organocatalysts for the domino
reaction between -enals and N-protected hydroxylamines, Tetrahedron:
a,a-Diarylprolinol-
a,b
[6] (a) J. Podlech, D. Seebach, The Arndt–Eistert reaction in peptide chemistry: a
facile access to homopeptides, Angew. Chem. Int. Ed. 34 (1995) 471–472;
Asymmetry 21 (2010) 2659–2670;
249
250
251
252
(d) G.L. Zhao, S.Z. Lin, A. Korotvicka, et al., Asymmetric synthesis of Maraviroc
(UK-427 857), Adv. Synth. Catal. 352 (2010) 2291–2298.
[16] Q.Y. Dou, Y.Q. Tu, Y. Zhang, et al., Spiro-pyrrolidine-catalyzed asymmetric
conjugate addition of hydroxylamine to enals and 2,4-dienals, Adv. Synth.
Catal. 358 (2016) 874–879.
(b) G. Guichard, S. Abele, D. Seebach, Preparation of N-fmoc-protected
3-amino acids and their use as building blocks for the solid-phase synthesis
of -peptides, Helv. Chim. Acta 81 (1998) 187–206.
[7] (a) P.W. Sutton, A. Bradley, M.R. Elsegood, et al., Design and synthesis of a novel
cyclo- -tetrapeptide, Tetrahedron Lett. 40 (1999) 2629–2632;
(b) J. Farras, X. Ginesta, P.W. Sutton, et al., 3-Amino acids by nucleophilic ring-
b2-and
b
292
293
b
253
254
255
b
[17] (a) L.F. Tietze, U. Beifuss, Sequential transformations in organic chemistry: a
synthetic strategy with a future, Angew. Chem. Int. Ed. Engl. 32 (1993) 131–
163;
294
295
296
297
298
299
b
opening of N-nosyl aziridines, Tetrahedron 57 (2001) 7665–7674.
[8] (a) X.G. Li, T.K. Kanerva, Lipase-involved strategy to the enantiomers of 4-
(b) L.F. Tietze, Domino reactions in organic synthesis, Chem. Rev. 96 (1996)
115–136;
(c) A. Padwa, S.K. Bur, The domino way to heterocycles, Tetrahedron 63 (2007)
256
257
258
259
260
261
262
263
264
265
benzyl-b-lactamas a key intermediate in the preparation of b-phenylalanine
derivatives, Adv. Synth. Catal. 348 (2006) 197–205;
(b) J. Kaman, M. Forro, F. Fulop, Enzyme-catalysed kinetic resolution of N,O-
diacetyl derivatives of cyclic 1,3-amino alcohols, Tetrahedron: Asymmetry 12
(2001) 1881–1886;
5341–5378.
[18] G. Sirasani, T. Paul, R.B. Andrade, Sequencing cross-metathesis and non-
metathesis reactions to rapidly access building blocks for synthesis,
Tetrahedron 67 (2011) 2191–2205.
[19] pKa values measured in water, in: D.D. Perrin, E.P. Serjeant, B. Dempsey (Eds.),
pKa Predictions for Organic Acids and Bases, Champman and Hall, London,
1981.
300
301
(c) C. Palomo, M. Oiarbide, S. Bindi, A concise
b-lactam route to short peptide
segments containing
b,b-disubstituted
b
-amino acids, J. Org. Chem. 63 (1998)
302
2469–2474;
(d) G. Tasnadi, E. Forro, F. Fulop, Improved enzymatic syntheses of valuable
b
-arylalkyl- -amino acid enantiomers, Org. Biomol. Chem. 8 (2010) 793–799.
b
[20] E. Dalcanale, F. Montanari, Selective oxidation of aldehydes to carboxylic acids
303
304
[9] (a) C.W. Jefford, J.B. Wang, An enantiospecific synthesis of
Tetrahedron Lett. 34 (1993) 1111–1114;
b-amino acids,
with sodium chlorite-hydrogen peroxide, J. Org. Chem. 51 (1986) 567–569.
266
267
[21] M. Seki, K. Matsumoto, A novel approach to homochiral
b-amino acids,
(b) C.W. Jefford, J. Mcnulty, Z.H. Lu, et al., The enantioselective synthesis of
Tetrahedron Lett. 37 (1996) 3165–3168.
Please cite this article in press as: H.-T. Jiang, et al., Concise synthesis of valuable chiral N-Boc-b-benzyl-b-amino acid via construction of chiral
N-Boc-3-benzyl-5-oxoisoxazolidine through cross-Metathesis/conjugate addition/oxidation, Chin. Chem. Lett. (2016), http://dx.doi.org/